CN112509638A - 人类hla染色体区域杂合性缺失的分析方法和分析处理装置 - Google Patents
人类hla染色体区域杂合性缺失的分析方法和分析处理装置 Download PDFInfo
- Publication number
- CN112509638A CN112509638A CN202011404354.4A CN202011404354A CN112509638A CN 112509638 A CN112509638 A CN 112509638A CN 202011404354 A CN202011404354 A CN 202011404354A CN 112509638 A CN112509638 A CN 112509638A
- Authority
- CN
- China
- Prior art keywords
- hla
- gene
- percentage
- recipient
- transplantation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000000349 chromosome Anatomy 0.000 title claims abstract description 49
- 238000004458 analytical method Methods 0.000 title claims abstract description 28
- 238000012545 processing Methods 0.000 title claims abstract description 16
- 238000012163 sequencing technique Methods 0.000 claims abstract description 70
- 238000002054 transplantation Methods 0.000 claims abstract description 48
- 238000012217 deletion Methods 0.000 claims abstract description 14
- 230000037430 deletion Effects 0.000 claims abstract description 14
- 108090000623 proteins and genes Proteins 0.000 claims description 107
- 238000001914 filtration Methods 0.000 claims description 25
- 210000004027 cell Anatomy 0.000 claims description 14
- 238000004364 calculation method Methods 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 9
- 102100028972 HLA class I histocompatibility antigen, A alpha chain Human genes 0.000 claims description 6
- 102100036241 HLA class II histocompatibility antigen, DQ beta 1 chain Human genes 0.000 claims description 6
- 102100040485 HLA class II histocompatibility antigen, DRB1 beta chain Human genes 0.000 claims description 6
- 102100028976 HLA class I histocompatibility antigen, B alpha chain Human genes 0.000 claims description 5
- 102100028971 HLA class I histocompatibility antigen, C alpha chain Human genes 0.000 claims description 5
- 108010075704 HLA-A Antigens Proteins 0.000 claims description 5
- 101150000578 HLA-B gene Proteins 0.000 claims description 5
- 101150035071 HLA-C gene Proteins 0.000 claims description 5
- 101150111527 HLA-DPB1 gene Proteins 0.000 claims description 5
- 101150046128 HLA-DQB1 gene Proteins 0.000 claims description 5
- 108010039343 HLA-DRB1 Chains Proteins 0.000 claims description 5
- 101150018610 HLA-DRB1 gene Proteins 0.000 claims description 5
- 230000002759 chromosomal effect Effects 0.000 claims description 5
- 108700028369 Alleles Proteins 0.000 claims description 4
- 238000012935 Averaging Methods 0.000 claims description 4
- 108010058607 HLA-B Antigens Proteins 0.000 claims description 4
- 108010052199 HLA-C Antigens Proteins 0.000 claims description 4
- 238000007405 data analysis Methods 0.000 claims description 4
- 108010065026 HLA-DQB1 antigen Proteins 0.000 claims description 3
- 239000002773 nucleotide Substances 0.000 claims description 2
- 125000003729 nucleotide group Chemical group 0.000 claims description 2
- 238000003556 assay Methods 0.000 claims 3
- 101150118346 HLA-A gene Proteins 0.000 claims 2
- 102100031618 HLA class II histocompatibility antigen, DP beta 1 chain Human genes 0.000 claims 1
- 108010045483 HLA-DPB1 antigen Proteins 0.000 claims 1
- 238000001514 detection method Methods 0.000 abstract description 11
- 101100284398 Bos taurus BoLA-DQB gene Proteins 0.000 description 14
- 101001100327 Homo sapiens RNA-binding protein 45 Proteins 0.000 description 9
- 238000011134 hematopoietic stem cell transplantation Methods 0.000 description 8
- 102100038823 RNA-binding protein 45 Human genes 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 210000004881 tumor cell Anatomy 0.000 description 4
- 101150044325 DRB1 gene Proteins 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 101150076489 B gene Proteins 0.000 description 2
- 101150111062 C gene Proteins 0.000 description 2
- 206010068051 Chimerism Diseases 0.000 description 2
- 108010067148 HLA-DQbeta antigen Proteins 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 230000017188 evasion or tolerance of host immune response Effects 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 210000002865 immune cell Anatomy 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 208000031404 Chromosome Aberrations Diseases 0.000 description 1
- 208000009329 Graft vs Host Disease Diseases 0.000 description 1
- 241000535824 Mastacembelocleidus bam Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 231100000005 chromosome aberration Toxicity 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000005553 drilling Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000004700 fetal blood Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 208000024908 graft versus host disease Diseases 0.000 description 1
- 201000005787 hematologic cancer Diseases 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000024200 hematopoietic and lymphoid system neoplasm Diseases 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 208000002154 non-small cell lung carcinoma Diseases 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
Landscapes
- Bioinformatics & Cheminformatics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Computational Biology (AREA)
- Analytical Chemistry (AREA)
- Evolutionary Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Theoretical Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (10)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011404354.4A CN112509638B (zh) | 2020-12-04 | 2020-12-04 | 人类hla染色体区域杂合性缺失的分析方法和分析处理装置 |
PCT/CN2021/085090 WO2022116456A1 (zh) | 2020-12-04 | 2021-04-01 | 人类hla染色体区域杂合性缺失的分析方法和分析处理装置 |
US17/522,841 US20220180965A1 (en) | 2020-12-04 | 2021-11-09 | Analysis method and analysis processing apparatus for loss of heterozygosity (loh) of human leukocyte antigen (hla) |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011404354.4A CN112509638B (zh) | 2020-12-04 | 2020-12-04 | 人类hla染色体区域杂合性缺失的分析方法和分析处理装置 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112509638A true CN112509638A (zh) | 2021-03-16 |
CN112509638B CN112509638B (zh) | 2021-12-03 |
Family
ID=74969875
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011404354.4A Active CN112509638B (zh) | 2020-12-04 | 2020-12-04 | 人类hla染色体区域杂合性缺失的分析方法和分析处理装置 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN112509638B (zh) |
WO (1) | WO2022116456A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022116456A1 (zh) * | 2020-12-04 | 2022-06-09 | 深圳荻硕贝肯精准医学有限公司 | 人类hla染色体区域杂合性缺失的分析方法和分析处理装置 |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090177487A1 (en) * | 2008-01-07 | 2009-07-09 | Tera Eerkes | Methods for Assessing Genetic Compatibility |
CN101575643A (zh) * | 2009-05-31 | 2009-11-11 | 中国人民解放军第二军医大学 | 一种检测异基因造血干细胞移植后供受嵌合率的方法 |
CN103074444A (zh) * | 2013-02-25 | 2013-05-01 | 苏州晶因生物科技有限公司 | 组织相容性抗原决定簇基因高通量测序的hla基因分型方法 |
CN104004817A (zh) * | 2013-02-22 | 2014-08-27 | 哈佛大学 | 利用极体或胚胎的单细胞基因组测序来选择试管婴儿的胚胎 |
CN105986011A (zh) * | 2015-01-30 | 2016-10-05 | 深圳华大基因研究院 | 一种杂合性缺失的检测方法 |
CN106755535A (zh) * | 2017-03-01 | 2017-05-31 | 上海荻硕贝肯医学检验所有限公司 | 用于检测人类cyp2c19基因多态性的引物、探针、试剂盒及方法 |
WO2019014667A1 (en) * | 2017-07-14 | 2019-01-17 | The Regents Of The University Of California | NEW METHODS FOR PREDICTING THE RISK OF GRAFT REJECTION |
CN110100014A (zh) * | 2016-10-31 | 2019-08-06 | 香港科技大学 | 用于检测阿尔茨海默病基因变体的组合物、方法和试剂盒 |
CN110913896A (zh) * | 2017-07-14 | 2020-03-24 | 弗朗西斯.克里克研究所 | 肿瘤中hla等位基因的分析及其用途 |
CN111091868A (zh) * | 2019-12-23 | 2020-05-01 | 江苏先声医学诊断有限公司 | 一种染色体非整倍体的分析方法及系统 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6302048B2 (ja) * | 2013-05-08 | 2018-03-28 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 次世代システムを用いるhla遺伝子アンプリコンのディープシーケンシングにより混合物を定量解析することによる固形臓器移植片拒絶の非侵襲的早期検出 |
CN110551803A (zh) * | 2019-06-18 | 2019-12-10 | 华夏源(上海)细胞基因工程股份有限公司 | 一种人类hla基因多态性引物插入或缺失的测序方法 |
CN112509638B (zh) * | 2020-12-04 | 2021-12-03 | 深圳荻硕贝肯精准医学有限公司 | 人类hla染色体区域杂合性缺失的分析方法和分析处理装置 |
-
2020
- 2020-12-04 CN CN202011404354.4A patent/CN112509638B/zh active Active
-
2021
- 2021-04-01 WO PCT/CN2021/085090 patent/WO2022116456A1/zh active Application Filing
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090177487A1 (en) * | 2008-01-07 | 2009-07-09 | Tera Eerkes | Methods for Assessing Genetic Compatibility |
CN101575643A (zh) * | 2009-05-31 | 2009-11-11 | 中国人民解放军第二军医大学 | 一种检测异基因造血干细胞移植后供受嵌合率的方法 |
CN104004817A (zh) * | 2013-02-22 | 2014-08-27 | 哈佛大学 | 利用极体或胚胎的单细胞基因组测序来选择试管婴儿的胚胎 |
CN103074444A (zh) * | 2013-02-25 | 2013-05-01 | 苏州晶因生物科技有限公司 | 组织相容性抗原决定簇基因高通量测序的hla基因分型方法 |
CN105986011A (zh) * | 2015-01-30 | 2016-10-05 | 深圳华大基因研究院 | 一种杂合性缺失的检测方法 |
CN110100014A (zh) * | 2016-10-31 | 2019-08-06 | 香港科技大学 | 用于检测阿尔茨海默病基因变体的组合物、方法和试剂盒 |
CN106755535A (zh) * | 2017-03-01 | 2017-05-31 | 上海荻硕贝肯医学检验所有限公司 | 用于检测人类cyp2c19基因多态性的引物、探针、试剂盒及方法 |
WO2019014667A1 (en) * | 2017-07-14 | 2019-01-17 | The Regents Of The University Of California | NEW METHODS FOR PREDICTING THE RISK OF GRAFT REJECTION |
CN110913896A (zh) * | 2017-07-14 | 2020-03-24 | 弗朗西斯.克里克研究所 | 肿瘤中hla等位基因的分析及其用途 |
CN111091868A (zh) * | 2019-12-23 | 2020-05-01 | 江苏先声医学诊断有限公司 | 一种染色体非整倍体的分析方法及系统 |
Non-Patent Citations (5)
Title |
---|
KUANZHEN LIAO 等: "Analysis of high-resolution human leucocyte antigen allele polymorphism in 3788 Han Chinese patients with leukaemia", 《BRITISH JOURNAL OF HAEMATOLOGY》 * |
LUCA VAGO 等: "Genomic Loss of Mismatched Human Leukocyte Antigen and Leukemia Immune Escape From Haploidentical Graft-Versus-Leukemia", 《SEMINARS IN ONCOLOGY》 * |
SHANNON R. MCCURDY 等: "Loss of the Mismatched Human Leukocyte Antigen Haplotype in Two Acute Myelogenous Leukemia Relapses after Haploidentical Bone Marrow Transplantation with Posttransplantation Cyclophosphamide", 《LEUKEMIA》 * |
王季石: "CAR_T和PD_1单克隆抗体在急性髓系白血病治疗中的进展和趋势", 《中国实验血液学杂志》 * |
陈晓晴 等: "高分辨熔解曲线技术检测HLA-G14bp插入/缺失突变方法的建立及初步应用", 《中国卫生检验杂志》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022116456A1 (zh) * | 2020-12-04 | 2022-06-09 | 深圳荻硕贝肯精准医学有限公司 | 人类hla染色体区域杂合性缺失的分析方法和分析处理装置 |
Also Published As
Publication number | Publication date |
---|---|
CN112509638B (zh) | 2021-12-03 |
WO2022116456A1 (zh) | 2022-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Langefeld et al. | Transancestral mapping and genetic load in systemic lupus erythematosus | |
Park et al. | Genome sequencing of the extinct Eurasian wild aurochs, Bos primigenius, illuminates the phylogeography and evolution of cattle | |
Parson et al. | Evaluation of next generation mtGenome sequencing using the Ion Torrent Personal Genome Machine (PGM) | |
Yamamoto et al. | Capturing differential allele-level expression and genotypes of all classical HLA loci and haplotypes by a new capture RNA-seq method | |
CN104254618A (zh) | 母体血浆中胎儿dna分数的基于大小的分析 | |
CN103221551A (zh) | Hla基因型别-snp连锁数据库、其构建方法、以及hla分型方法 | |
Riman et al. | Characterization of NIST human mitochondrial DNA SRM-2392 and SRM-2392-I standard reference materials by next generation sequencing | |
Tigano et al. | Chromosome-level assembly of the Atlantic silverside genome reveals extreme levels of sequence diversity and structural genetic variation | |
Karimi et al. | Comparison of linkage disequilibrium levels in Iranian indigenous cattle using whole genome SNPs data | |
CN112088220A (zh) | 替代标志物及用于肿瘤突变负荷测定的方法 | |
CN112885406B (zh) | 检测hla杂合性缺失的方法及系统 | |
CN112509638B (zh) | 人类hla染色体区域杂合性缺失的分析方法和分析处理装置 | |
Lee et al. | Genome‐defined African ancestry is associated with distinct mutations and worse survival in patients with diffuse large B‐cell lymphoma | |
Li et al. | Comparative sequence alignment reveals River Buffalo genomic structural differences compared with cattle | |
Berger et al. | Forensic characterization and statistical considerations of the CaDNAP 13-STR panel in 1,184 domestic dogs from Germany, Austria, and Switzerland | |
Martin et al. | Adaptive evolution of major histocompatibility complex class I immune genes and disease associations in coastal juvenile sea turtles | |
KR101770962B1 (ko) | 유전자 서열 기반 개인 마커에 관한 정보를 제공하는 방법 및 이를 이용한 장치 | |
Ryu et al. | Genetic association of marbling score with intragenic nucleotide variants at selection signals of the bovine genome | |
RU2535157C1 (ru) | Способ выявления рецессивных факторов наследственной предрасположенности к раку молочной железы | |
Wang et al. | Identification of homozygous regions with adverse effects on the five economic traits of Duroc pigs | |
CN106119406B (zh) | 多发性肉芽肿血管炎及微小动脉炎的基因分型诊断试剂盒及使用方法 | |
Pierini et al. | Targeted analysis of polymorphic loci from low-coverage shotgun sequence data allows accurate genotyping of HLA genes in historical human populations | |
US20220180965A1 (en) | Analysis method and analysis processing apparatus for loss of heterozygosity (loh) of human leukocyte antigen (hla) | |
CN105838720A (zh) | Ptprq基因突变体及其应用 | |
Parker et al. | Fixation effects on variant calling in a clinical resequencing panel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Huang Xiaojun Inventor after: Zheng Zhongzheng Inventor after: Liao Kuanzhen Inventor after: Du Keming Inventor after: Yuan Zhiyang Inventor before: Zheng Zhongzheng Inventor before: He Qingqing Inventor before: Liao Kuanzhen Inventor before: Tu Xiaonian Inventor before: Yuan Zhiyang |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Analysis methods and processing devices for loss of heterozygosity in human HLA chromosome regions Effective date of registration: 20230719 Granted publication date: 20211203 Pledgee: Industrial Bank Co.,Ltd. Shanghai Nanhui Branch Pledgor: SHANGHAI TISSUEBANK MEDICAL LABORATORY Co.,Ltd.|SHENZHEN TISSUEBANK PRECISION MEDICINE CO.,LTD.|SHANGHAI TISSUEBANK BIOTECHNOLOGY Co.,Ltd.|Shanghai dishuobeiken Gene Technology Co.,Ltd.|SHANGHAI TISSUEBANK BIOTECHNOLOGY CO.,LTD. Registration number: Y2023310000384 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Granted publication date: 20211203 Pledgee: Industrial Bank Co.,Ltd. Shanghai Nanhui Branch Pledgor: SHANGHAI TISSUEBANK MEDICAL LABORATORY Co.,Ltd.|SHENZHEN TISSUEBANK PRECISION MEDICINE CO.,LTD.|SHANGHAI TISSUEBANK BIOTECHNOLOGY Co.,Ltd.|Shanghai dishuobeiken Gene Technology Co.,Ltd.|SHANGHAI TISSUEBANK BIOTECHNOLOGY CO.,LTD. Registration number: Y2023310000384 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Analysis methods and processing devices for loss of heterozygosity in human HLA chromosome regions Granted publication date: 20211203 Pledgee: Industrial Bank Co.,Ltd. Shanghai Nanhui Branch Pledgor: SHANGHAI TISSUEBANK MEDICAL LABORATORY Co.,Ltd.|SHENZHEN TISSUEBANK PRECISION MEDICINE CO.,LTD.|SHANGHAI TISSUEBANK BIOTECHNOLOGY Co.,Ltd.|Shanghai dishuobeiken Gene Technology Co.,Ltd.|SHANGHAI TISSUEBANK BIOTECHNOLOGY CO.,LTD. Registration number: Y2024310000533 |